Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Mech Ageing Dev. 2006 Feb;127(2):208-12. Epub 2005 Nov 7.

Juvenile Huntington's disease: does a dosage-effect pathogenic mechanism differ from the classical adult disease?

Author information

  • 1Neurogenetics Unit, IRCCS Neuromed, Pozzilli, IS, Italy. neurogen@neuromed.it

Abstract

Huntington's disease (HD) is caused by a CAG repeat mutation translating as a polyglutamine (poly(Q)) expansion in the huntingtin protein, whose main pathogenic mechanism is a gain of toxic function. In the case of large expansions beyond 60 repeats onset may result in juvenile HD (JHD, onset before 20 years of age). However, the triplet number does not represent the only onset modifier even in case of large expansions, mechanisms other than the size of the mutation contribute to the phenotype. In this review we discuss the possibility that some of the pathogenic mechanisms contributing to age at onset and progression may differ in the early onset HD compared with the classical adult pathology.

PMID:
16274727
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk